中国医学前沿杂志(电子版)
中國醫學前沿雜誌(電子版)
중국의학전연잡지(전자판)
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2014年
10期
120-122
,共3页
刘玉海%王静%王焕珍%高世海%王强
劉玉海%王靜%王煥珍%高世海%王彊
류옥해%왕정%왕환진%고세해%왕강
较大肝癌%经皮瘤体内无水乙醇注射%射频消融%临床效果
較大肝癌%經皮瘤體內無水乙醇註射%射頻消融%臨床效果
교대간암%경피류체내무수을순주사%사빈소융%림상효과
Large liver cancer%Percutaneous intratumoral ethanol injection%Radiofrequency ablation%Clinical effect
目的:探讨经皮瘤体内无水乙醇注射(PEI)联合射频消融(RFA)治疗较大肝癌的临床效果。方法将106例较大肝癌(直径5~10 cm)患者随机分为两组,两组患者均采用局部麻醉和静脉镇痛,对照组患者行肝动脉栓塞化疗(TACE)联合RFA,观察组患者行PEI联合RFA。统计两组患者肿瘤坏死率,复发率和治疗6、12、18、24个月后的存活率。结果观察组患者肿瘤完全坏死41例(77.36%),部分坏死12例(22.64%),对照组患者肿瘤完全坏死39例(73.58%),部分坏死14例(26.42%),组间比较差异无显著性(P>0.05);观察组患者复发率为9.43%,对照组为13.21%,组间比较差异无显著性(P>0.05);两组患者治疗6、12、18、24个月后的存活率比较差异无显著性(P>0.05);观察组患者有包膜的瘤灶疗效优于对照组,差异有显著性(P<0.05)。结论经皮瘤体内PEI联合RFA治疗较大肝癌疗效确切,可有效提高患者存活率,降低复发率,具有积极的推广价值。
目的:探討經皮瘤體內無水乙醇註射(PEI)聯閤射頻消融(RFA)治療較大肝癌的臨床效果。方法將106例較大肝癌(直徑5~10 cm)患者隨機分為兩組,兩組患者均採用跼部痳醉和靜脈鎮痛,對照組患者行肝動脈栓塞化療(TACE)聯閤RFA,觀察組患者行PEI聯閤RFA。統計兩組患者腫瘤壞死率,複髮率和治療6、12、18、24箇月後的存活率。結果觀察組患者腫瘤完全壞死41例(77.36%),部分壞死12例(22.64%),對照組患者腫瘤完全壞死39例(73.58%),部分壞死14例(26.42%),組間比較差異無顯著性(P>0.05);觀察組患者複髮率為9.43%,對照組為13.21%,組間比較差異無顯著性(P>0.05);兩組患者治療6、12、18、24箇月後的存活率比較差異無顯著性(P>0.05);觀察組患者有包膜的瘤竈療效優于對照組,差異有顯著性(P<0.05)。結論經皮瘤體內PEI聯閤RFA治療較大肝癌療效確切,可有效提高患者存活率,降低複髮率,具有積極的推廣價值。
목적:탐토경피류체내무수을순주사(PEI)연합사빈소융(RFA)치료교대간암적림상효과。방법장106례교대간암(직경5~10 cm)환자수궤분위량조,량조환자균채용국부마취화정맥진통,대조조환자행간동맥전새화료(TACE)연합RFA,관찰조환자행PEI연합RFA。통계량조환자종류배사솔,복발솔화치료6、12、18、24개월후적존활솔。결과관찰조환자종류완전배사41례(77.36%),부분배사12례(22.64%),대조조환자종류완전배사39례(73.58%),부분배사14례(26.42%),조간비교차이무현저성(P>0.05);관찰조환자복발솔위9.43%,대조조위13.21%,조간비교차이무현저성(P>0.05);량조환자치료6、12、18、24개월후적존활솔비교차이무현저성(P>0.05);관찰조환자유포막적류조료효우우대조조,차이유현저성(P<0.05)。결론경피류체내PEI연합RFA치료교대간암료효학절,가유효제고환자존활솔,강저복발솔,구유적겁적추엄개치。
ObjectiveTo study the percutaneous intratumoral ethanol injection (PEI) combined with radiofrequency ablation (RFA) treatment of the clinical effect of large hepatocellular carcinoma.Method106 cases of large hepatocellular carcinoma (diameter 5~10 cm) were randomly divided into two groups, control group treated by PEI+RFA, observation group underwent TACE+RFA; statistics two groups of patients with tumor necrosis rate, recurrence rate and 6, 12, 18, 24 months of the survival rate.ResultObservation group of patients with complete tumor necrosis was 41 cases (77.36%), partial necrosis of 12 cases (22.64%), complete tumor necrosis was 39 patients (73.58%) with control group, 14 cases (26.42%) had partial necrosis. The recurrence rated in observation group was 9.43%, control group was 13.21%, there was no significant difference between two groups (P>0.05); two group were treating 6, 12, 18, 24 month later of survival difference was not signiifcant (P>0.05); control group better than control group in a tumor capsule and the curative effect, the difference was statistically signiifcant (P<0.05).ConclusionPercutaneous intratumoral ethanol injection combined with radiofrequency ablation for the treatment of large hepatocellular carcinoma has curative effect, can effectively improve survival rate, reduce recurrence rate, and has clinical signiifcance.